GlassScriptPhysician profile
Cheryl A Brady
NPI 1083676043
$12,750.97
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $66.83 · 2024: $75.95 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,747 · Travel and Lodging: $4,469 · Food and Beverage: $1,343 · Education: $24.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,747.30 |
| Travel and Lodging | $4,469.17 |
| Food and Beverage | $1,343.07 |
| Education | $24.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $12,379.47 | 2024-2025 | Vafseo |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2021 | |
| Travere Therapeutics, INC. | $59.76 | 2025 | |
| Vifor Pharma, INC. | $49.56 | 2022 | |
| Scpharmaceuticals INC. | $40.95 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $33.13 | 2025 | Jynarque |
| Calliditas Therapeutics US INC. | $31.05 | 2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $22.75 | 2025 | |
| Fresenius USA Marketing, INC. | $17.27 | 2022 | |
| Nxstage Medical, INC. | $17.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.